Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Cosmo Pharmaceuticals receives FDA complete response letter for Methylene Blue MMX

May 24, 2018

CARB-X supports MicrobeDx's development of UTI diagnostic system

May 16, 2018

Interpace to launch new thyroid test ThyGeNEXT

May 15, 2018

FDA identifies deficiencies during NDA review of Methylene Blue MMX

May 11, 2018

Photoacoustic imaging agents for Alzheimer's disease described in KAERI patent

April 30, 2018

Completion of phase I study of tozuleristide in pediatric brain tumor surgery

April 25, 2018

FDA clears use of Bruker Maldi Biotyper CA system to identify C. auris

April 23, 2018

FDA finalizes guidance on NGS-based tests

April 13, 2018

5-HTT radiotracer [11C]DASB may predict remission after antidepressant treatment

April 11, 2018

Loxo Oncology and Illumina to develop pan-cancer companion diagnostics

April 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...